SAFE-T-DOSE Trademark

Trademark Overview


On Wednesday, August 8, 2012, a trademark application was filed for SAFE-T-DOSE with the United States Patent and Trademark Office. The USPTO has given the SAFE-T-DOSE trademark a serial number of 85698804. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, February 23, 2024. This trademark is owned by Asepsis Pharmaceuticals Inc.. The SAFE-T-DOSE trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; Antiemetics; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Ocular pharmaceuticals; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the treatment and prevention of d...
safe-t-dose

General Information


Serial Number85698804
Word MarkSAFE-T-DOSE
Filing DateWednesday, August 8, 2012
Status710 - CANCELLED - SECTION 8
Status DateFriday, February 23, 2024
Registration Number4385439
Registration DateTuesday, August 13, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 15, 2013

Trademark Statements


Goods and ServicesAnti-infectives; Antiemetics; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Ocular pharmaceuticals; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the treatment and prevention of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for wounds; Pharmaceutical products for ophthalmological use; Potassium preparations for pharmaceutical purposes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, February 23, 2024
Primary Code005
First Use Anywhere DateTuesday, January 31, 2012
First Use In Commerce DateTuesday, January 31, 2012

Trademark Owner History


Party NameAsepsis Pharmaceuticals Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSarasota, FL 34234

Party NameAsepsis Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNorth Stonington, CT 06359

Party NameAsepsis Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorth Stonington, CT 06359

Trademark Events


Event DateEvent Description
Friday, February 23, 2024CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Saturday, August 13, 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, October 31, 2018NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Wednesday, October 31, 2018REGISTERED - SEC. 8 (6-YR) ACCEPTED
Wednesday, October 31, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, October 26, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 26, 2018TEAS SECTION 8 RECEIVED
Monday, August 13, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, April 30, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 13, 2013REGISTERED-PRINCIPAL REGISTER
Friday, July 12, 2013NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, July 11, 2013LAW OFFICE REGISTRATION REVIEW COMPLETED
Thursday, July 11, 2013ASSIGNED TO LIE
Friday, June 21, 2013ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, June 18, 2013STATEMENT OF USE PROCESSING COMPLETE
Friday, May 17, 2013USE AMENDMENT FILED
Tuesday, June 18, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, May 17, 2013TEAS STATEMENT OF USE RECEIVED
Tuesday, March 12, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 15, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 15, 2013PUBLISHED FOR OPPOSITION
Wednesday, December 26, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, December 5, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 5, 2012ASSIGNED TO EXAMINER
Thursday, August 16, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, August 11, 2012NEW APPLICATION ENTERED